Top Markets
#1 MarsCoin MarsCoin +48.28%
#2 Palladium Network Palladium Network +27.97%
#3 Siren Siren +27.75%
#4 Status Status +21.38%
#5 Useless Coin Useless Coin +16.56%
#6 BankrCoin BankrCoin +15.25%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#8 Bedrock Bedrock +14.18%
#9 Ankr Network Ankr Network +12.74%
#10 Arweave Arweave +12.66%
Coin of the day
MarsCoin MarsCoin
Settings
Language
ENGLISH
Currency
USD
Theme
Guangzhou Innogen Pharmaceutl Grp Co Ltd Guangzhou Innogen Pharmaceutl Grp Co Ltd

Guangzhou Innogen Pharmaceutl Grp Co Ltd

2591
Rank in Stocks #18189
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based... Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Share Price
$0.45733627
Market Cap
$208.92M
Change (1 day)
0.56%
Change (1 year)
-91.54%
Country
CN
Trade Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)

Category

Healthcare
Dividend history for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)
Guangzhou Innogen Pharmaceutl Grp Co Ltd (stock symbol: 2591) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH